Kathy Giusti, M.B.A. ’85, founder and CEO of the Multiple Myeloma Research Foundation (MMRF), will address this year's imminent graduates of Harvard Business School as Class Day speaker. She founded the MMRF in 1998 after being diagnosed with multiple myeloma. This spring, Time magazine named her one of the "100 most influential people" in the world. Multiple myeloma is a cancer of plasma cells—white blood cells that produce antibodies; it affects from one to four people per 100,000 and constitutes 1 percent of all cancers. Before starting MMRF, Giusti was an executive with pharmaceutical companies, and she has sought to encourage the development of drugs to treat the disease using a business model, rather than an academic model, of drug development. The MMRF is the world's top funder of myeloma research: it has raised more than $165 million to fund research.
Multiple myeloma research crusader Kathy Giusti to speak at HBS Class Day
Multiple myeloma research crusader Kathy Giusti to speak at HBS Class Day
The founder of the Multiple Myeloma Research Foundation will speak at Harvard Business School Class Day.
You might also like
Harvard Faculty of Arts and Sciences Appoints a New Finance Dean
Warren Petrofsky joins at a crucial moment when the FAS is dealing with a $350 million deficit.
Harvard Graduates Can Donate Directly to Their Houses on Housing Day
A new initiative encourages small-dollar donations for improving student life.
A Cap on A’s at Harvard? Students and Faculty Raise Concerns at Town Hall
Dozens debate the grade inflation proposal that faculty will discuss next week.
Most popular
Explore More From Current Issue
Inside Harvard’s Most Egalitarian School
The Extension School is open to everyone. Expect to work—hard.
What Bonobos Teach Us About Female Power and Cooperation
A Harvard scientist expands our understanding of our closest living relatives.